• helpdesk@Lucintel.com
  • |
  • +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Immunohematology Market. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


The future of the immunohematology market looks promising with opportunities in pretransfusion testing, ABO and Rh typing, antibody detection, cross matching, investigation of immune hemolysis, perinatal testing, blood group phenotyping/genotyping, and leucocyte & platelet serology. The global immunohematology market is expected to grow with a CAGR of 4%-6% from 2020 to 2025. The major drivers for this market are increasing number of blood banks and trauma centers in developed countries, rising prevalence rate of various hematological disorders, increasing number of blood donation awareness programs in developing countries, and technological advancements in immunohematology.

A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global immunohematology market report, please download the report brochure.

 

 
In this market, reagents is the largest product of immunohematology, whereas hospitals is the largest end use. Growth in various segments of the immunohematology market are given below:


 

 
The study includes trends and forecast for the global immunohematology market by product, application, disease, end use, and region as follows:

By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Immunohematology Reagents
  • Immunohematology Analyzers
  • Automated Analyzers
  • Semi-Automated Analyzers / Non-Automated Analyzers 
 
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Pretransfusion Testing
  • ABO and Rh Typing
  • Antibody Detection
  • Cross Matching
  • Investigation of Immune Hemolysis
  • Perinatal Testing
  • Blood Group Phenotyping / Genotyping
  • Leucocyte and Platelet Serology 

By Disease [Value ($ Million) shipment analysis for 2014 – 2025]: 
  • Blood-Related Diseases
  • HIV
  • Hepatitis 

By End Use [Value ($ Million) shipment analysis for 2014 – 2025]: 
  • Hospitals
  • Blood Banks
  • Diagnostic Laboratories

By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
  • North America
    • United States
    • Canada 
    • Mexico
  • Europe
    • United Kingdom
    • Spain
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
  • The Rest of the World
    • Brazil
 

Some of the immunohematology companies profiled in this report include Bio-Rad Laboratories, Grifols, Ortho Clinical Diagnostics, IMMUCOR, Abbott Laboratories, Beckman Coulter, Thermo Fisher Scientific, Becton, Dickinson and Company, Merck, and Siemens Healthineers.

Lucintel forecasts that immunohematology reagents will remain the largest product segment over the forecast period due to growing number of blood banks and increased use of reagents in immunohematology tests. 

Within this market, hospitals will remain the largest end use segment over the forecast period due to the mandatory rule that hospitals need to check donated blood for infections, set parameters of hematology components, and perform pre-transfusion compatibility tests of donors and recipients.

North America will remain the largest region over the forecast period due to the high number of trauma centers and blood bank facilities in this region.



 
Features of the Global Immunohematology Market
 
  • Market Size Estimates: Global immunohematology market size estimation in terms of value ($M) shipment.
  • Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
  • Segmentation Analysis: Global immunohematology market size by various segments, such as product, application, disease, and end use in terms of value.
  • Regional Analysis: Global immunohematology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different product, application, disease, end use, and region for the global immunohematology market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global immunohematology market.
  • Analysis of competitive intensity of the industry based on Porter’s Five Forces model.




 
This report answers following key questions
 
Q.1 What are some of the most promising potential, high-growth opportunities for the global immunohematology market by product (immunohematology reagents, immunohematology analyzers, automated analyzers, and semi-automated analyzers / non-automated analyzers), application (pretransfusion testing, ABO and Rh typing, antibody detection, cross matching, investigation of immune hemolysis, perinatal testing, blood group phenotyping / genotyping, and leucocyte and platelet serology), disease (blood-related diseases, HIV, and hepatitis), end use (hospitals, blood banks, and diagnostic laboratories), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global immunohematology market?
Q.5 What are the business risks and threats to the global immunohematology market?
Q.6 What are emerging trends in this immunohematology market and the reasons behind them?
Q.7 What are some changing demands of customers in this immunohematology market?
Q.8 What are the new developments in this immunohematology market? Which companies are leading these developments?
Q.9 Who are the major players in this immunohematology market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this immunohematology market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global immunohematology market?

 



Report Scope



Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates)
2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Immunohematology Reagents, Immunohematology Analyzers, Automated Analyzers, and Semi-Automated Analyzers / Non-Automated Analyzers), Application (Pretransfusion Testing, ABO and Rh Typing, Antibody Detection, Cross Matching, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping / Genotyping, and Leucocyte and Platelet Serology), Disease (Blood-Related Diseases, HIV, and Hepatitis), and End Use (Hospitals, Blood Banks, and Diagnostic Laboratories)

Regional Scope

North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)

Customization 10% Customization without Any Additional Cost

Table of Contents


1. Executive Summary

2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2014 to 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Immunohematology Market Trends and Forecast
3.3: Global Immunohematology Market by Product 
3.3.1: Immunohematology Reagents
3.3.2: Immunohematology Analyzers
3.3.3: Automated Analyzers
3.3.4: Semi-Automated Analyzers / Non-Automated Analyzers
3.4: Global Immunohematology Market by Application
3.4.1: Pretransfusion Testing
3.4.2: ABO and Rh Typing
3.4.3: Antibody Detection
3.4.4: Cross Matching
3.4.5: Investigation of ImmuneHhemolysis
3.4.6: Perinatal Testing
3.4.7: Blood Group Phenotyping / Genotyping
3.4.8: Leucocyte and Platelet Serology
3.5: Global Immunohematology Market by Disease
3.5.1: Blood-Related Diseases
3.5.2: HIV
3.5.3: Hepatitis 
3.6: Global Immunohematology Market by End Use
3.6.1: Hospitals
3.6.2: Blood Banks
3.6.3: Diagnostic Laboratories

4. Market Trends and Forecast Analysis by Region
4.1: Global Immunohematology Market by Region
4.2: North American Immunohematology Market
4.2.1: Market by Product: Immunohematology Reagents, Immunohematology Analyzers, Automated Analyzers, and Semi-Automated Analyzers / Non-Automated Analyzers 
4.2.2: Market by Application: Pretransfusion Testing, ABO and Rh Typing, Antibody Detection, Cross Matching, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping / Genotyping, and Leucocyte and Platelet Serology
4.2.3: Market by Disease: Blood-Related Diseases, HIV, and Hepatitis 
4.2.4: Market by End Use: Hospitals, Blood Banks, and Diagnostic Laboratories
4.2.5: The United States Immunohematology Market
4.2.6: The Canadian Immunohematology Market
4.2.7: The Mexican Immunohematology Market
4.3: European Immunohematology Market
4.3.1: Market by Product: Immunohematology Reagents, Immunohematology Analyzers, Automated Analyzers, and Semi-Automated Analyzers / Non-Automated Analyzers 
4.3.2: Market by Application: Pretransfusion Testing, ABO and Rh Typing, Antibody Detection, Cross Matching, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping / Genotyping, and Leucocyte and Platelet Serology
4.3.3: Market by Disease: Blood-Related Diseases, HIV, and Hepatitis 
4.3.4: Market by End Use: Hospitals, Blood Banks, and Diagnostic Laboratories
4.3.5: The United Kingdom Immunohematology Market
4.3.6: The Spanish Immunohematology Market
4.3.7: The German Immunohematology Market
4.3.8: The French Immunohematology Market
4.4: APAC Immunohematology Market
4.4.1: Market by Product: Immunohematology Reagents, Immunohematology Analyzers, Automated Analyzers, and Semi-Automated Analyzers / Non-Automated Analyzers 
4.4.2: Market by Application: Pretransfusion Testing, ABO and Rh Typing, Antibody Detection, Cross Matching, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping / Genotyping, and Leucocyte and Platelet Serology
4.4.3: Market by Disease: Blood-Related Diseases, HIV, and Hepatitis 
4.4.4: Market by End Use: Hospitals, Blood Banks, and Diagnostic Laboratories
4.4.5: The Chinese Immunohematology Market
4.4.6: The Indian Immunohematology Market
4.4.7: The Japanese Immunohematology Market
4.5: ROW Immunohematology Market
4.5.1: Market by Product: Immunohematology Reagents, Immunohematology Analyzers, Automated Analyzers, and Semi-Automated Analyzers / Non-Automated Analyzers 
4.5.2: Market by Application: Pretransfusion Testing, ABO and Rh Typing, Antibody Detection, Cross Matching, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping / Genotyping, and Leucocyte and Platelet Serology
4.5.3: Market by Disease: Blood-Related Diseases, HIV, and Hepatitis 
4.5.4: Market by End Use: Hospitals, Blood Banks, and Diagnostic Laboratories
4.5.5: Brazilian Immunohematology Market

5. Competitor Analysis
5.1: Market Share Analysis
5.2: Product Portfolio Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis

6. Cost Structure Analysis
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin

7. Growth Opportunities and Strategic Analysis
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Immunohematology Market by Product 
7.1.2: Growth Opportunities for the Global Immunohematology Market by Application
7.1.3: Growth Opportunities for the Global Immunohematology Market by Disease
7.1.4: Growth Opportunities for the Global Immunohematology Market by End Use
7.1.5: Growth Opportunities for the Global Immunohematology Market by Region
7.2: Emerging Trends in the Global Immunohematology Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Immunohematology Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Immunohematology  Market
7.3.4: Certification and Licensing

8. Company Profiles of Leading Players
8.1: Bio-Rad Laboratories
8.2: Grifols
8.3: Ortho Clinical Diagnostics
8.4: IMMUCOR
8.5: Abbott Laboratories
8.6: Beckman Coulter
8.7: Thermo Fisher Scientific
8.8: Becton, Dickinson and Company
8.9: Merck
8.10: Siemens Healthineers
 
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Immunohematology Market: Trends, Forecast and Competitive Analysis Full Report $ 4,850
150 - page report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Below is a brief summary of the primary interviews that were conducted by job function for this report.